Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?.

Frontiers in immunology

Juno JA, van Bockel D, Kent SJ, Kelleher AD, Zaunders JJ, Munier CM.
PMID: 28167943
Front Immunol. 2017 Jan 23;8:19. doi: 10.3389/fimmu.2017.00019. eCollection 2017.

CD4 T cells with cytotoxic function were once thought to be an artifact due to long-term

Cite
Juno JA, van Bockel D, Kent SJ, et al. Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?. Front Immunol. 2017;8:19doi: 10.3389/fimmu.2017.00019.
Juno, J. A., van Bockel, D., Kent, S. J., Kelleher, A. D., Zaunders, J. J., & Munier, C. M. (2017). Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?. Frontiers in immunology, 819. https://doi.org/10.3389/fimmu.2017.00019
Juno, Jennifer A, et al. "Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?." Frontiers in immunology vol. 8 (2017): 19. doi: https://doi.org/10.3389/fimmu.2017.00019
Juno JA, van Bockel D, Kent SJ, Kelleher AD, Zaunders JJ, Munier CM. Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?. Front Immunol. 2017 Jan 23;8:19. doi: 10.3389/fimmu.2017.00019. eCollection 2017. PMID: 28167943; PMCID: PMC5253382.
Copy Download .nbib Format: NLM
Cardiac assessment of patients with late stage Duchenne muscular dystrophy.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van Bockel EA, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, van den Berg MP, Slart RH, Aarts LP, Tulleken JE.
PMID: 19789685
Neth Heart J. 2009 Jun;17(6):232-7. doi: 10.1007/BF03086253.

Background. Duchenne muscular dystrophy (DMD) patients used to die mainly from pulmonary problems. However, as advances in respiratory care increase life expectancy, mortality due to cardiomyopathy rises. Echocardiography remains the standard diagnostic modality for cardiomyopathy in DMD patients, but...

Cite
van Bockel EA, Lind JS, Zijlstra JG, et al. Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth Heart J. 2009;17(6):232-7doi: 10.1007/BF03086253.
van Bockel, E. A., Lind, J. S., Zijlstra, J. G., Wijkstra, P. J., Meijer, P. M., van den Berg, M. P., Slart, R. H., Aarts, L. P., & Tulleken, J. E. (2009). Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 17(6), 232-7. https://doi.org/10.1007/BF03086253
van Bockel, E A P, et al. "Cardiac assessment of patients with late stage Duchenne muscular dystrophy." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 17,6 (2009): 232-7. doi: https://doi.org/10.1007/BF03086253
van Bockel EA, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, van den Berg MP, Slart RH, Aarts LP, Tulleken JE. Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth Heart J. 2009 Jun;17(6):232-7. doi: 10.1007/BF03086253. PMID: 19789685; PMCID: PMC2711248.
Copy Download .nbib Format: NLM
Circulating gluten-specific, but not CMV-specific, CD39.

Clinical & translational immunology

Cook L, Munier CML, Seddiki N, Hardy MY, Anderson RP, Zaunders J, Tye-Din JA, Kelleher AD, van Bockel D.
PMID: 31956412
Clin Transl Immunology. 2020 Jan 12;9(1):e1096. doi: 10.1002/cti2.1096. eCollection 2020.

OBJECTIVES: Understanding the T cell receptor (TCR) repertoire of regulatory CD4METHODS: We used the OX40 assay to isolate antigen-specific Tregs by induced surface co-expression of CD25, OX40 and CD39. RACE PCR amplification and Sanger sequencing of the TCR β...

Cite
Cook L, Munier CML, Seddiki N, et al. Circulating gluten-specific, but not CMV-specific, CD39. Clin Transl Immunology. 2020;9(1):e1096doi: 10.1002/cti2.1096.
Cook, L., Munier, C. M. L., Seddiki, N., Hardy, M. Y., Anderson, R. P., Zaunders, J., Tye-Din, J. A., Kelleher, A. D., & van Bockel, D. (2020). Circulating gluten-specific, but not CMV-specific, CD39. Clinical & translational immunology, 9(1), e1096. https://doi.org/10.1002/cti2.1096
Cook, Laura, et al. "Circulating gluten-specific, but not CMV-specific, CD39." Clinical & translational immunology vol. 9,1 (2020): e1096. doi: https://doi.org/10.1002/cti2.1096
Cook L, Munier CML, Seddiki N, Hardy MY, Anderson RP, Zaunders J, Tye-Din JA, Kelleher AD, van Bockel D. Circulating gluten-specific, but not CMV-specific, CD39. Clin Transl Immunology. 2020 Jan 12;9(1):e1096. doi: 10.1002/cti2.1096. eCollection 2020. PMID: 31956412; PMCID: PMC6955237.
Copy Download .nbib Format: NLM
T-cell responses in primary HIV-1 infection.

Current opinion in HIV and AIDS

Streeck H, van Bockel D, Kelleher A.
PMID: 19372944
Curr Opin HIV AIDS. 2008 Jan;3(1):52-9. doi: 10.1097/COH.0b013e3282f269d6.

PURPOSE OF REVIEW: Important immunological events, especially involving T cells, occur during primary HIV-1 infection. The qualitative nature of the primary immune response to the virus may determine long-term outcome. Whereas CD4 T cells are being rapidly depleted, CD8...

Cite
Streeck H, van Bockel D, Kelleher A. T-cell responses in primary HIV-1 infection. Curr Opin HIV AIDS. 2008;3(1):52-9doi: 10.1097/COH.0b013e3282f269d6.
Streeck, H., van Bockel, D., & Kelleher, A. (2008). T-cell responses in primary HIV-1 infection. Current opinion in HIV and AIDS, 3(1), 52-9. https://doi.org/10.1097/COH.0b013e3282f269d6
Streeck, Hendrik, et al. "T-cell responses in primary HIV-1 infection." Current opinion in HIV and AIDS vol. 3,1 (2008): 52-9. doi: https://doi.org/10.1097/COH.0b013e3282f269d6
Streeck H, van Bockel D, Kelleher A. T-cell responses in primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan;3(1):52-9. doi: 10.1097/COH.0b013e3282f269d6. PMID: 19372944.
Copy Download .nbib Format: NLM
Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Lardenoye JH, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, van Bockel JH, Quax PH.
PMID: 19758909
EuroIntervention. 2005 Aug;1(2):236-43.

AIMS: Intimal hyperplasia, characterised by smooth muscle cell migration and proliferation, requires extracellular matrix degradation which is mediated by matrix metalloproteinases (MMPs). In this study, the effect of tetracycline derived doxycycline, a specific MMP inhibitor of both activity and...

Cite
Lardenoye JH, de Vries MR, Deckers M, et al. Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention. 2005;1(2):236-43
Lardenoye, J. H., de Vries, M. R., Deckers, M., van Lent, N., Hanemaaijer, R., van Bockel, J. H., & Quax, P. H. (2005). Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(2), 236-43.
Lardenoye, J H P, et al. "Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,2 (2005): 236-43.
Lardenoye JH, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, van Bockel JH, Quax PH. Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention. 2005 Aug;1(2):236-43. PMID: 19758909.
Copy Download .nbib Format: NLM
Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Frontiers in immunology

Zaunders J, van Bockel D.
PMID: 23630526
Front Immunol. 2013 Apr 24;4:95. doi: 10.3389/fimmu.2013.00095. eCollection 2013.

Long-term non-progressors (LTNP) were identified after 10-15 years of the epidemic, and have been the subject of intense investigation ever since. In a small minority of cases, infection with nef/3'LTR deleted attenuated viral strains allowed control over viral replication....

Cite
Zaunders J, van Bockel D. Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol. 2013;4:95doi: 10.3389/fimmu.2013.00095.
Zaunders, J., & van Bockel, D. (2013). Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Frontiers in immunology, 495. https://doi.org/10.3389/fimmu.2013.00095
Zaunders, John, and van Bockel, David. "Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease." Frontiers in immunology vol. 4 (2013): 95. doi: https://doi.org/10.3389/fimmu.2013.00095
Zaunders J, van Bockel D. Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol. 2013 Apr 24;4:95. doi: 10.3389/fimmu.2013.00095. eCollection 2013. PMID: 23630526; PMCID: PMC3633949.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries